Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TOR1B: a predictor of bone metastasis in breast cancer patients. | Sci Rep | 2023 | 36707670 | PubTator, text mining | PubMed |
| Structural investigation of CDCA3-Cdh1 protein-protein interactions using in vitro studies and molecular dynamics simulation. | Protein Sci | 2023 | 36691744 | PubTator, text mining | PubMed |
| Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer. | Curr Issues Mol Biol | 2023 | 36661515 | PubTator, text mining | PubMed |
| Inactivation of Mad2B Enhances Apoptosis in Human Cervical Cancer Cell Line upon Cisplatin-Induced DNA Damage. | Biomol Ther (Seoul) | 2023 | 36642928 | PubTator, text mining | PubMed |
| Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma. | Hereditas | 2023 | 36635779 | PubTator, text mining | PubMed |
| A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma. | BMC Pulm Med | 2023 | 36635678 | PubTator, text mining | PubMed |
| Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. | J Cancer | 2023 | 36605491 | PubTator, text mining | PubMed |
| High throughput sequencing revealed enhanced cell cycle signaling in SLE patients. | Sci Rep | 2023 | 36599883 | PubTator, text mining | PubMed |
| Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity. | J Med Virol | 2023 | 36597912 | PubTator, text mining | PubMed |
| Host cell cycle checkpoint as antiviral target for SARS-CoV-2 revealed by integrative transcriptome and proteome analyses. | Signal Transduct Target Ther | 2023 | 36596760 | PubTator, text mining | PubMed |
| Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside. | Biomed Pharmacother | 2023 | 36521246 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Kinetochore-catalyzed MCC formation: A structural perspective. | IUBMB Life | 2023 | 36518060 | PubTator, text mining | PubMed |
| A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients. | Leukemia | 2023 | 36509894 | PubTator, text mining | PubMed |
| Increased expression of HMMR in renal cell carcinoma is an independent prognostic factor. | Oncol Lett | 2023 | 36478897 | PubTator, text mining | PubMed |
| Spatial separation of phosphatase and kinase activity within the Bub complex is required for proper mitosis. | J Mol Cell Biol | 2023 | 36441015 | PubTator, text mining | PubMed |
| Hypoxia promotes epithelial-mesenchymal transition in lung cancer cells via regulating the NRF2/miR‑27a/BUB1 pathway. | Clin Transl Oncol | 2023 | 36309619 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. | Curr Pharm Biotechnol | 2023 | 35762549 | PubTator, text mining | PubMed |
Direct transcriptomic comparison of xenobiotic metabolism and toxicity pathway induction of airway epithelium models at an air-liquid interface generated from induced pluripotent stem cells and primary bronchial epithelial cells. | Cell Biol Toxicol | 2023 | 35641671 | PubTator, text mining | PubMed |
| Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. | Hepatology | 2023 | 35262957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=24